The future of Faraday Future looks to be secure following a cash injection of US$2 billion (almost RM8 billion) from Evergrande Health. With the investment, the Hong Kong holding company now owns a 45% stake in the electric car company, according to reports by Autocar UK and The Verge.

Last year, Faraday Future raised US$984 million (almost RM4 billion) by selling off some of its shares to investors. Together with this latest inflow of cash, the company will be able to carry on with its plan to put the FF 91 into production, with Faraday Future CEO Jia Yueting saying will take place later this year.

Unveiled in early 2017, the FF 91 was an electric crossover that featured four electric motors with a total system output of 1,050 hp and 1,800 Nm of torque. The motors drew power from a 130 kWh battery that offered as much as 700 km of range, and allowed for an acceleration time from 0-96 km/h in 2.39 seconds.

Aside from the Tesla-rivalling performance, the FF 91 also came with a suite of sensors that enabled a host of autonomous functions. There’s also facial recognition technology, smart dimming glass technology, interior cameras and many more.

The FF 91 will first be introduced in China and the United States, with production taking place in the respective countries – Hanford, California and Nansha, Guangzhou. Faraday Future is the strategic partner of LeEco, a Chinese company that deals in electronics and electric vehicles – the latter via its LeSEE division.

GALLERY: Faraday Future FF 91